Global Neglected Tropical Diseases Drugs and Vaccine Market Research Report 2023

Report ID: 2005715 | Published Date: Jan 2025 | No. of Page: 88 | Base Year: 2024 | Rating: 4.5 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
        1.2.2 Malaria
        1.2.3 Ebola
        1.2.4 Dengue
        1.2.5 Chagas
        1.2.6 Leishmaniasis
        1.2.7 Other
    1.3 Market by Application
        1.3.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application: 2017 VS 2021 VS 2028
        1.3.2 Drugs
        1.3.3 Vaccines
    1.4 Study Objectives
    1.5 Years Considered
2 Global Growth Trends
    2.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Perspective (2017-2028)
    2.2 Neglected Tropical Diseases Drugs and Vaccine Growth Trends by Region
        2.2.1 Neglected Tropical Diseases Drugs and Vaccine Market Size by Region: 2017 VS 2021 VS 2028
        2.2.2 Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Region (2017-2022)
        2.2.3 Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Region (2023-2028)
    2.3 Neglected Tropical Diseases Drugs and Vaccine Market Dynamics
        2.3.1 Neglected Tropical Diseases Drugs and Vaccine Industry Trends
        2.3.2 Neglected Tropical Diseases Drugs and Vaccine Market Drivers
        2.3.3 Neglected Tropical Diseases Drugs and Vaccine Market Challenges
        2.3.4 Neglected Tropical Diseases Drugs and Vaccine Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Revenue
        3.1.1 Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Revenue (2017-2022)
        3.1.2 Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Players (2017-2022)
    3.2 Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Neglected Tropical Diseases Drugs and Vaccine Revenue
    3.4 Global Neglected Tropical Diseases Drugs and Vaccine Market Concentration Ratio
        3.4.1 Global Neglected Tropical Diseases Drugs and Vaccine Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2021
    3.5 Neglected Tropical Diseases Drugs and Vaccine Key Players Head office and Area Served
    3.6 Key Players Neglected Tropical Diseases Drugs and Vaccine Product Solution and Service
    3.7 Date of Enter into Neglected Tropical Diseases Drugs and Vaccine Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Neglected Tropical Diseases Drugs and Vaccine Breakdown Data by Type
    4.1 Global Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Type (2017-2022)
    4.2 Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Type (2023-2028)
5 Neglected Tropical Diseases Drugs and Vaccine Breakdown Data by Application
    5.1 Global Neglected Tropical Diseases Drugs and Vaccine Historic Market Size by Application (2017-2022)
    5.2 Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Application (2023-2028)
6 North America
    6.1 North America Neglected Tropical Diseases Drugs and Vaccine Market Size (2017-2028)
    6.2 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2017-2022)
    6.3 North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2028)
    6.4 United States
    6.5 Canada
7 Europe
    7.1 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size (2017-2028)
    7.2 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2017-2022)
    7.3 Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2028)
    7.4 Germany
    7.5 France
    7.6 U.K.
    7.7 Italy
    7.8 Russia
    7.9 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size (2017-2028)
    8.2 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2017-2022)
    8.3 Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2028)
    8.4 China
    8.5 Japan
    8.6 South Korea
    8.7 Southeast Asia
    8.8 India
    8.9 Australia
9 Latin America
    9.1 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size (2017-2028)
    9.2 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2017-2022)
    9.3 Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2028)
    9.4 Mexico
    9.5 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size (2017-2028)
    10.2 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2017-2022)
    10.3 Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2028)
    10.4 Turkey
    10.5 Saudi Arabia
    10.6 UAE
11 Key Players Profiles
    11.1 Artecef BV
        11.1.1 Artecef BV Company Detail
        11.1.2 Artecef BV Business Overview
        11.1.3 Artecef BV Neglected Tropical Diseases Drugs and Vaccine Introduction
        11.1.4 Artecef BV Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
        11.1.5 Artecef BV Recent Development
    11.2 GlaxoSmithKline
        11.2.1 GlaxoSmithKline Company Detail
        11.2.2 GlaxoSmithKline Business Overview
        11.2.3 GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Introduction
        11.2.4 GlaxoSmithKline Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
        11.2.5 GlaxoSmithKline Recent Development
    11.3 AstraZeneca
        11.3.1 AstraZeneca Company Detail
        11.3.2 AstraZeneca Business Overview
        11.3.3 AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Introduction
        11.3.4 AstraZeneca Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
        11.3.5 AstraZeneca Recent Development
    11.4 Novartis
        11.4.1 Novartis Company Detail
        11.4.2 Novartis Business Overview
        11.4.3 Novartis Neglected Tropical Diseases Drugs and Vaccine Introduction
        11.4.4 Novartis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
        11.4.5 Novartis Recent Development
    11.5 Sanofi-Aventis
        11.5.1 Sanofi-Aventis Company Detail
        11.5.2 Sanofi-Aventis Business Overview
        11.5.3 Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Introduction
        11.5.4 Sanofi-Aventis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
        11.5.5 Sanofi-Aventis Recent Development
    11.6 Ranbaxy Labs
        11.6.1 Ranbaxy Labs Company Detail
        11.6.2 Ranbaxy Labs Business Overview
        11.6.3 Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Introduction
        11.6.4 Ranbaxy Labs Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
        11.6.5 Ranbaxy Labs Recent Development
    11.7 Lupin
        11.7.1 Lupin Company Detail
        11.7.2 Lupin Business Overview
        11.7.3 Lupin Neglected Tropical Diseases Drugs and Vaccine Introduction
        11.7.4 Lupin Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
        11.7.5 Lupin Recent Development
    11.8 Macleods Pharmaceuticals
        11.8.1 Macleods Pharmaceuticals Company Detail
        11.8.2 Macleods Pharmaceuticals Business Overview
        11.8.3 Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Introduction
        11.8.4 Macleods Pharmaceuticals Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
        11.8.5 Macleods Pharmaceuticals Recent Development
    11.9 Cipla
        11.9.1 Cipla Company Detail
        11.9.2 Cipla Business Overview
        11.9.3 Cipla Neglected Tropical Diseases Drugs and Vaccine Introduction
        11.9.4 Cipla Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
        11.9.5 Cipla Recent Development
    11.10 Romark Laboratories
        11.10.1 Romark Laboratories Company Detail
        11.10.2 Romark Laboratories Business Overview
        11.10.3 Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Introduction
        11.10.4 Romark Laboratories Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
        11.10.5 Romark Laboratories Recent Development
    11.11 Toyama Chemica
        11.11.1 Toyama Chemica Company Detail
        11.11.2 Toyama Chemica Business Overview
        11.11.3 Toyama Chemica Neglected Tropical Diseases Drugs and Vaccine Introduction
        11.11.4 Toyama Chemica Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
        11.11.5 Toyama Chemica Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
    Table 2. Key Players of Malaria
    Table 3. Key Players of Ebola
    Table 4. Key Players of Dengue
    Table 5. Key Players of Chagas
    Table 6. Key Players of Leishmaniasis
    Table 7. Key Players of Other
    Table 8. Global Neglected Tropical Diseases Drugs and Vaccine Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
    Table 9. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
    Table 10. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2017-2022) & (US$ Million)
    Table 11. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Region (2017-2022)
    Table 12. Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Region (2023-2028) & (US$ Million)
    Table 13. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Region (2023-2028)
    Table 14. Neglected Tropical Diseases Drugs and Vaccine Market Trends
    Table 15. Neglected Tropical Diseases Drugs and Vaccine Market Drivers
    Table 16. Neglected Tropical Diseases Drugs and Vaccine Market Challenges
    Table 17. Neglected Tropical Diseases Drugs and Vaccine Market Restraints
    Table 18. Global Neglected Tropical Diseases Drugs and Vaccine Revenue by Players (2017-2022) & (US$ Million)
    Table 19. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Players (2017-2022)
    Table 20. Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neglected Tropical Diseases Drugs and Vaccine as of 2021)
    Table 21. Ranking of Global Top Neglected Tropical Diseases Drugs and Vaccine Companies by Revenue (US$ Million) in 2021
    Table 22. Global 5 Largest Players Market Share by Neglected Tropical Diseases Drugs and Vaccine Revenue (CR5 and HHI) & (2017-2022)
    Table 23. Key Players Headquarters and Area Served
    Table 24. Key Players Neglected Tropical Diseases Drugs and Vaccine Product Solution and Service
    Table 25. Date of Enter into Neglected Tropical Diseases Drugs and Vaccine Market
    Table 26. Mergers & Acquisitions, Expansion Plans
    Table 27. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Type (2017-2022) & (US$ Million)
    Table 28. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Type (2017-2022)
    Table 29. Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Type (2023-2028) & (US$ Million)
    Table 30. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Type (2023-2028)
    Table 31. Global Neglected Tropical Diseases Drugs and Vaccine Market Size by Application (2017-2022) & (US$ Million)
    Table 32. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Application (2017-2022)
    Table 33. Global Neglected Tropical Diseases Drugs and Vaccine Forecasted Market Size by Application (2023-2028) & (US$ Million)
    Table 34. Global Neglected Tropical Diseases Drugs and Vaccine Revenue Market Share by Application (2023-2028)
    Table 35. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2017-2022) & (US$ Million)
    Table 36. North America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2028) & (US$ Million)
    Table 37. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2017-2022) & (US$ Million)
    Table 38. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2028) & (US$ Million)
    Table 39. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2017-2022) & (US$ Million)
    Table 40. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size by Region (2023-2028) & (US$ Million)
    Table 41. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2017-2022) & (US$ Million)
    Table 42. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2028) & (US$ Million)
    Table 43. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2017-2022) & (US$ Million)
    Table 44. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size by Country (2023-2028) & (US$ Million)
    Table 45. Artecef BV Company Detail
    Table 46. Artecef BV Business Overview
    Table 47. Artecef BV Neglected Tropical Diseases Drugs and Vaccine Product
    Table 48. Artecef BV Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022) & (US$ Million)
    Table 49. Artecef BV Recent Development
    Table 50. GlaxoSmithKline Company Detail
    Table 51. GlaxoSmithKline Business Overview
    Table 52. GlaxoSmithKline Neglected Tropical Diseases Drugs and Vaccine Product
    Table 53. GlaxoSmithKline Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022) & (US$ Million)
    Table 54. GlaxoSmithKline Recent Development
    Table 55. AstraZeneca Company Detail
    Table 56. AstraZeneca Business Overview
    Table 57. AstraZeneca Neglected Tropical Diseases Drugs and Vaccine Product
    Table 58. AstraZeneca Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022) & (US$ Million)
    Table 59. AstraZeneca Recent Development
    Table 60. Novartis Company Detail
    Table 61. Novartis Business Overview
    Table 62. Novartis Neglected Tropical Diseases Drugs and Vaccine Product
    Table 63. Novartis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022) & (US$ Million)
    Table 64. Novartis Recent Development
    Table 65. Sanofi-Aventis Company Detail
    Table 66. Sanofi-Aventis Business Overview
    Table 67. Sanofi-Aventis Neglected Tropical Diseases Drugs and Vaccine Product
    Table 68. Sanofi-Aventis Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022) & (US$ Million)
    Table 69. Sanofi-Aventis Recent Development
    Table 70. Ranbaxy Labs Company Detail
    Table 71. Ranbaxy Labs Business Overview
    Table 72. Ranbaxy Labs Neglected Tropical Diseases Drugs and Vaccine Product
    Table 73. Ranbaxy Labs Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022) & (US$ Million)
    Table 74. Ranbaxy Labs Recent Development
    Table 75. Lupin Company Detail
    Table 76. Lupin Business Overview
    Table 77. Lupin Neglected Tropical Diseases Drugs and Vaccine Product
    Table 78. Lupin Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022) & (US$ Million)
    Table 79. Lupin Recent Development
    Table 80. Macleods Pharmaceuticals Company Detail
    Table 81. Macleods Pharmaceuticals Business Overview
    Table 82. Macleods Pharmaceuticals Neglected Tropical Diseases Drugs and Vaccine Product
    Table 83. Macleods Pharmaceuticals Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022) & (US$ Million)
    Table 84. Macleods Pharmaceuticals Recent Development
    Table 85. Cipla Company Detail
    Table 86. Cipla Business Overview
    Table 87. Cipla Neglected Tropical Diseases Drugs and Vaccine Product
    Table 88. Cipla Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022) & (US$ Million)
    Table 89. Cipla Recent Development
    Table 90. Romark Laboratories Company Detail
    Table 91. Romark Laboratories Business Overview
    Table 92. Romark Laboratories Neglected Tropical Diseases Drugs and Vaccine Product
    Table 93. Romark Laboratories Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022) & (US$ Million)
    Table 94. Romark Laboratories Recent Development
    Table 95. Toyama Chemica Company Detail
    Table 96. Toyama Chemica Business Overview
    Table 97. Toyama Chemica Neglected Tropical Diseases Drugs and VaccineProduct
    Table 98. Toyama Chemica Revenue in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022) & (US$ Million)
    Table 99. Toyama Chemica Recent Development
    Table 100. Research Programs/Design for This Report
    Table 101. Key Data Information from Secondary Sources
    Table 102. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Type: 2021 VS 2028
    Figure 2. Malaria Features
    Figure 3. Ebola Features
    Figure 4. Dengue Features
    Figure 5. Chagas Features
    Figure 6. Leishmaniasis Features
    Figure 7. Other Features
    Figure 8. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Application in 2021 & 2028
    Figure 9. Drugs Case Studies
    Figure 10. Vaccines Case Studies
    Figure 11. Neglected Tropical Diseases Drugs and Vaccine Report Years Considered
    Figure 12. Global Neglected Tropical Diseases Drugs and Vaccine Market Size (US$ Million), Year-over-Year: 2017-2028
    Figure 13. Global Neglected Tropical Diseases Drugs and Vaccine Market Size, (US$ Million), 2017 VS 2021 VS 2028
    Figure 14. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Region: 2021 VS 2028
    Figure 15. Global Neglected Tropical Diseases Drugs and Vaccine Market Share by Players in 2021
    Figure 16. Global Top Neglected Tropical Diseases Drugs and Vaccine Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neglected Tropical Diseases Drugs and Vaccine as of 2021)
    Figure 17. The Top 10 and 5 Players Market Share by Neglected Tropical Diseases Drugs and Vaccine Revenue in 2021
    Figure 18. North America Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 19. North America Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2017-2028)
    Figure 20. United States Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 21. Canada Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 22. Europe Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 23. Europe Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2017-2028)
    Figure 24. Germany Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 25. France Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 26. U.K. Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 27. Italy Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 28. Russia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 29. Nordic Countries Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 30. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 31. Asia-Pacific Neglected Tropical Diseases Drugs and Vaccine Market Share by Region (2017-2028)
    Figure 32. China Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 33. Japan Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 34. South Korea Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 35. Southeast Asia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 36. India Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 37. Australia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 38. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 39. Latin America Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2017-2028)
    Figure 40. Mexico Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 41. Brazil Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 42. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 43. Middle East & Africa Neglected Tropical Diseases Drugs and Vaccine Market Share by Country (2017-2028)
    Figure 44. Turkey Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 45. Saudi Arabia Neglected Tropical Diseases Drugs and Vaccine Market Size YoY Growth (2017-2028) & (US$ Million)
    Figure 46. Artecef BV Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
    Figure 47. GlaxoSmithKline Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
    Figure 48. AstraZeneca Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
    Figure 49. Novartis Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
    Figure 50. Sanofi-Aventis Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
    Figure 51. Ranbaxy Labs Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
    Figure 52. Lupin Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
    Figure 53. Macleods Pharmaceuticals Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
    Figure 54. Cipla Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
    Figure 55. Romark Laboratories Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
    Figure 56. Toyama Chemica Revenue Growth Rate in Neglected Tropical Diseases Drugs and Vaccine Business (2017-2022)
    Figure 57. Bottom-up and Top-down Approaches for This Report
    Figure 58. Data Triangulation
    Figure 59. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Artecef BV
GlaxoSmithKline
AstraZeneca
Novartis
Sanofi-Aventis
Ranbaxy Labs
Lupin
Macleods Pharmaceuticals
Cipla
Romark Laboratories
Toyama Chemica
Frequently Asked Questions
Neglected Tropical Diseases Drugs and Vaccine report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Neglected Tropical Diseases Drugs and Vaccine report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Neglected Tropical Diseases Drugs and Vaccine report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports